We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison of antigenicity between frozen section vs non−frozen section tissue blocks: An immunohistochemical study of antibodies commonly used in gynecologic pathology.
- Authors
Obaid, Quratulain; Nadji, Mehrdad; Schlumbrecht, Matthew; Pinto, Andre
- Abstract
Objectives Frozen section (FS) is a technique widely used intraoperatively to render a preliminary histopathologic diagnosis, allowing for immediate decisions at the time of surgery. We aimed to investigate potential variations in tissue antigenicity induced by rapid freezing in a variety of gynecologic tumor samples. Methods A total of 177 FS and 177 non–frozen section (NFS) tissue slides were tested using a panel of immunostains commonly used in gynecologic pathology, including hormone receptors (estrogen receptor, progesterone receptor), HER2, mismatch repair proteins (MSH6, PMS2), programmed cell death 1 ligand 1 (PD-L1), p53, napsin A, and ɑ-methylacyl coenzyme-A racemase. Immunohistochemistry results were categorized as positive or negative, and positive cases were subsequently scored based on the distribution and intensity of the staining. Certain immunostains, such as HER2, PD-L1, and p53, were scored according to the established guidelines. Results The overall concordance between FS and NFS blocks was 87%; among the 13% of discrepant cases, most (10.7%) were classified as minor, with only quantitative differences without foreseeable clinical significance. In 2.3% of cases, there were major qualitative changes with potential impact on disease management. Conclusions We concluded that FS tissue blocks may, in most cases, safely be used for immunohistochemical studies because most discrepant cases showed only minor differences in staining, with no anticipated clinical significance. Nevertheless, for certain markers, including HER2, p53, and PMS2, a NFS block is preferred when that option is available.
- Subjects
ESTROGEN receptors; HORMONE receptors; IMMUNOSTAINING; CELL death; DISEASE management; DNA mismatch repair
- Publication
American Journal of Clinical Pathology, 2024, Vol 162, Issue 6, p612
- ISSN
0002-9173
- Publication type
Academic Journal
- DOI
10.1093/ajcp/aqae080